Insider trading · Q3 2026 · CIK 1404644

Neurogene Inc. (NGNE) insider trading.

In Q3 2026, insiders at Neurogene Inc. reported 5 non-derivative transactions on 2 Forms 3, 4 and 5: 0 open-market purchases and 5 sales worth $340K.

Transactions
5
Purchases (P)
0
Sales (S)
5
Net shares, P minus S
-9,600
Insiders
1
Last filed
2026-07-07

Insiders

InsiderRelationshipTransactionsBuysSales
Cvijic Christine MikailDirector, Officer · President and CFO505

Transactions

5 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-07-07Cvijic Christine MikailS (D)4,200$36.1384,040Form 4
2026-07-06Cvijic Christine MikailS (D)600$36.0288,240Form 4
2026-07-02Cvijic Christine MikailS (D)2,531$34.5890,370Form 4
2026-07-02Cvijic Christine MikailS (D)1,530$35.2388,840Form 4
2026-07-01Cvijic Christine MikailS (D)739$34.0692,901Form 4

Transaction codes in this quarter

Get NGNE insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1404644&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · NGNE company page · Neurogene Inc. on SEC.gov

Questions

Are insiders buying or selling Neurogene Inc. (NGNE)?

In Q3 2026, insiders at Neurogene Inc. reported 5 non-derivative transactions on 2 Forms 3, 4 and 5: 0 open-market purchases and 5 sales worth $340K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Neurogene Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/ngne.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.